低剂量计算机断层扫描筛查中肺癌过度诊断的估计：丹麦肺癌筛查试验的二次分析。
Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening: A Secondary Analysis of the Danish Lung Cancer Screening Trial.
机构信息
The Research Unit for General Practice, Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Chronic Diseases Research Centre, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, Lisbon, Portugal.
出版信息
JAMA Intern Med. 2018 Oct 1;178(10):1420-1422. doi: 10.1001/jamainternmed.2018.3056.
Abstract
This study analyzes data from the Danish Lung Cancer Screening Trial to determine the amount of overdiagnosis of computed tomography–detected lung cancer.
摘要
本研究分析了丹麦肺癌筛查试验的数据，以确定计算机断层扫描检测到的肺癌的过度诊断程度。
相似文献
1
Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening: A Secondary Analysis of the Danish Lung Cancer Screening Trial.
JAMA Intern Med. 2018 Oct 1;178(10):1420-1422. doi: 10.1001/jamainternmed.2018.3056.
2
Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
Acad Radiol. 2015 Aug;22(8):976-82. doi: 10.1016/j.acra.2014.10.011. Epub 2015 Mar 13.
3
Overdiagnosis in Lung Cancer Screening can be Reduced to a Low, Manageable Level via a Multilayered Strategy Involving Perfecting Reporting Systems, Restricting Screening to High-Risk Groups, Developing Better Risk Stratification Models, and Improving Management Algorithms.
Acad Radiol. 2016 Jan;23(1):113-5. doi: 10.1016/j.acra.2015.09.006. Epub 2015 Oct 26.
4
Prognostic selection and long-term survival analysis to assess overdiagnosis risk in lung cancer screening randomized trials.
J Med Screen. 2021 Mar;28(1):39-47. doi: 10.1177/0969141320923030. Epub 2020 May 21.
5
Overdiagnosis Detrimental, Resection Consequential, NLST Challengeable.
Acad Radiol. 2016 Jan;23(1):112-3. doi: 10.1016/j.acra.2015.07.013. Epub 2015 Oct 23.
6
[Lung cancer screening with low-dose CT - Danish and international results].
Ugeskr Laeger. 2014 Oct 13;176(42).
7
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Thorax. 2012 Apr;67(4):296-301. doi: 10.1136/thoraxjnl-2011-200736. Epub 2012 Jan 27.
8
Can We Prevent the Usual Conundrum on Overdiagnosis in Lung Cancer Screening?
J Thorac Imaging. 2022 Nov 1;37(6):W92-W93. doi: 10.1097/RTI.0000000000000668. Epub 2022 Aug 10.
9
Do competing causes of mortality contribute to overdiagnosis in lung cancer screening?
Lung Cancer. 2021 Mar;153:21-24. doi: 10.1016/j.lungcan.2020.12.031. Epub 2020 Dec 30.
10
Incidental renal tumours on low-dose CT lung cancer screening exams.
J Med Screen. 2017 Jun;24(2):104-109. doi: 10.1177/0969141316657115. Epub 2016 Oct 9.
引用本文的文献
1
A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with Zr/I-Labeled Tinurilimab.
Adv Sci (Weinh). 2025 Jun;12(21):e2415689. doi: 10.1002/advs.202415689. Epub 2025 Apr 3.
2
Development and biological evaluation of a novel CEACAM6-targeted PET tracer for distinguishing malignant nodules in early-stage lung adenocarcinoma.
Eur J Nucl Med Mol Imaging. 2025 Jan 31. doi: 10.1007/s00259-025-07107-3.
3
The Evidence Effect: How Fact Boxes Shift Perceptions of Lung Cancer Screening in Austrian Medical Practice.
Cancer Med. 2024 Dec;13(23):e70453. doi: 10.1002/cam4.70453.
4
How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?
Eur Respir Rev. 2024 Jun 26;33(172). doi: 10.1183/16000617.0232-2023. Print 2024 Apr.
5
[Effectiveness Evaluation of Low-dose Spiral Computed Tomography
for Lung Cancer Screening in Minhang District of Shanghai].
Zhongguo Fei Ai Za Zhi. 2024 Jan 20;27(1):13-24. doi: 10.3779/j.issn.1009-3419.2023.102.46.
6
Impact of lung cancer screening with low-dose chest computed tomography on an older population: a retrospective cohort study.
Transl Lung Cancer Res. 2023 Oct 31;12(10):2068-2082. doi: 10.21037/tlcr-23-266. Epub 2023 Oct 23.
7
Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort.
J Clin Oncol. 2023 Sep 20;41(27):4360-4368. doi: 10.1200/JCO.22.02424. Epub 2023 Jun 28.
8
Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer.
Cancers (Basel). 2023 Mar 3;15(5):1595. doi: 10.3390/cancers15051595.
9
Non-small cell lung cancer in China.
Cancer Commun (Lond). 2022 Oct;42(10):937-970. doi: 10.1002/cac2.12359. Epub 2022 Sep 8.
10
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2.
本文引用的文献
1
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
Thorax. 2017 Sep;72(9):825-831. doi: 10.1136/thoraxjnl-2016-209825. Epub 2017 Apr 4.
2
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
Am J Respir Crit Care Med. 2016 Mar 1;193(5):542-51. doi: 10.1164/rccm.201505-1040OC.
3
Overdiagnosis in low-dose computed tomography screening for lung cancer.
JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738.
4
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Thorax. 2012 Apr;67(4):296-301. doi: 10.1136/thoraxjnl-2011-200736. Epub 2012 Jan 27.
5
Overdiagnosis in cancer.
J Natl Cancer Inst. 2010 May 5;102(9):605-13. doi: 10.1093/jnci/djq099. Epub 2010 Apr 22.
6
The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
J Thorac Oncol. 2009 May;4(5):608-14. doi: 10.1097/JTO.0b013e3181a0d98f.
Zotero 插件